+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma



No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma



Neoplasma 57(4): 377-381



To report the treatment outcome and possible survival difference between radical surgical treatment (enucleation) or stereotactic radiosurgery (SRS). LINAC stereotactic radiosurgery is an alternative treatment for posterior uveal melanoma used in Slovakia since 1999. The study analyzed patients treated for posterior uveal melanoma in the period 2001-2008. The aim of the study was to compare the relapse-free survival in the cohort of patients primarily treated with surgery (enucleation) or SRS. A total number of 84 patients were included, treatment was determined on a case-by-case basis. We reviewed the records of patients with ciliary body or choroidal melanoma treated by enucleation - 44 patients (52%) and SRS - 40 patients (48%). The therapeutic attitude was established on the basis of ophthalmoscopy, ultrasound (A, B mode), other ophthalmological findings, visual acuity, and general status of each patient. Volume of the tumor was calculated using the formula: "pi/6 x length x width x height" for each patient. All of the patients before decision to "conservative" attitude therapy underwent MRI examination. The therapeutic dose in SRS patients group was 35.0-38.0 Gy. The data were analyzed using Kaplan - Meier survival method for the differences in survival rates between the treatment groups, and afterwards by Cox s proportional hazard method with predictors involved. Among the baseline covariates evaluated, only age affected the prognosis for survival to a statistically important, however not significant degree. The risk of death among patients treated with enucleation relative to those treated with stereotaxy after adjustment for baseline characteristics of patients, age, and tumor volumes was not significant [1.82] (95% CI, 0.46 to 7.30; P = 0.396). The overall five-year survival rate for patients with posterior uveal melanoma was 72%. Treatment by either primary enucleation or SRS according to our results does not appear to influence the development of metastases in patients with uveal melanoma; the survival prognosis is essentially determined by the stage and character of the tumor. No survival difference attributable to stereotactic irradiation of uveal melanoma has been demonstrated in this retrospective study. A small difference is possible, but a clinically meaningful difference in mortality rates, whether from all causes or from metastatic melanoma, is unlikely. Treatment by either radical surgical attitude (enucleation) or "conservative" LINAC- SRS does not appear to influence the survival rate in patients with uveal melanoma.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 054630174

Download citation: RISBibTeXText

PMID: 20429631


Related references

Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation. Acta Ophthalmologica Scandinavica 81(4): 383-388, August, 2003

One-day session LINAC-based stereotactic radiosurgery of posterior uveal melanoma. European Journal of Ophthalmology 22(2): 226-235, 2012

Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients. Acta Ophthalmologica 96(8): 841-848, 2018

Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma. International Journal of Radiation Oncology, Biology, Physics 98(1): 152-158, 2017

Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma. Technology in Cancer Research & Treatment 5(4): 411-419, 2006

Gamma-knife-based stereotactic radiosurgery for medium- and large-sized posterior uveal melanoma. Graefe's Archive for Clinical and Experimental Ophthalmology 251(1): 285-294, 2013

Complications in patients with uveal melanoma after stereotactic radiosurgery and brachytherapy. Bratislavske Lekarske Listy 106(12): 401-406, 2006

The use of single fraction Leksell stereotactic radiosurgery in the treatment of uveal melanoma. Acta Ophthalmologica Scandinavica 74(6): 558-562, 1996

Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection. JAMA Ophthalmology 131(5): 630-637, 2013

Survival analysis of stereotactic radiosurgery compared to enucleation for the treatment of choroidal and ciliary body malignant melanoma. IOVS 42(4): S219, March 15, 2001

PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups. Ophthalmology 101(1): 56-62, 1994

Malignant melanoma of the eye treatment of posterior uveal lesions by cobalt 60 plaque radiotherapy vs. enucleation. Radiology 156(3): 801-804, 1985

Malignant melanoma of the eye: treatment of posterior uveal lesions by Co-60 plaque radiotherapy versus enucleation. Radiology 156(3): 801-803, 1985

Stereotactic radiosurgery of uveal melanoma with the Leksell Gamma-knife-indication, treatment plan, and short-term results. IOVS 39(4): S288, March 15, 1998

Regarding stereotactic radiosurgery for uveal melanoma. JAMA Ophthalmology 132(3): 367-368, 2014